|
08.10.2009
First drags of SOSP «Max-Well»
First drags of SOSP «Max-Well» were approved by Ukrainian Ministry of Health. The Ministry’s order is register the first pharmaceuticals of the company: Maxvirin (ribavirin), capsules 200 mg and Maxhistin (betahistine), pills 8 mg, 16 mgs, 24 mg.
Maxvirin is antiviral drug for treatment of chronic viral hepatitis C.
Maxhistin is drug for treatment of vestibular vertigo and Ménière's syndrome.
back to the news
|
